TABLE 2

Effects of different opioid antagonists on basal [35S]GTPγS binding in MOR cell membranes with or without agonists pretreatment

Maximal effects (Emax) are expressed as percentage of change from basal. Positive values indicate agonistic effects, whereas negative values indicate inverse agonist effects. Data are means ± S.D., n = 4 to 8.


Compound

No Pretreatment

Pretreatment
DAMGO
Morphine
EC50
Emax
EC50
Emax
EC50
Emax
nM % change nM % change nM % change
DAMGO 74 ± 13 92 ± 5 164 ± 59* 69 ± 7* N.D. N.D.
BNTX 402 ± 250 -7 ± 2** 31 ± 16* -13 ± 1*,** 57 ± 15* -14 ± 1*,**
Naloxone 2 ± 1 14 ± 1** 7 ± 2 -9 ± 1*,** N.D. -9 ± 3*,**
Naltrexone N.D. 29 ± 6** N.D. -8 ± 2*,** N.D. -8 ± 1*,**
6β -Naltrexol 3 ± 2 12 ± 1** N.D. 1 ± 2* N.D. 2 ± 5*
6β -Naltrexamide
3 ± 2
22 ± 1**
29 ± 15*
17 ± 1
N.D.
12 ± 6*
  • N.D., not determined.

  • * P < 0.01, compared with no pretreatment.

  • ** P < 0.01, compared with zero; ANOVA with Dunnett's post test.